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724 R. Nafae et al.Both groups were matched as regards age and body mass index (BMI). Pulmonary function param-
eters (FVC%, FEV1%, FEV1/FVC and PEFR%) and serum leptin level were measured before
starting the intervention in both groups and after starting it by three months.
Results: Reduction mammoplasty signiﬁcantly increases FVC% with non-signiﬁcant improve-
ment regarding BMI and serum leptin level. On the other hand, diet control regimen improves
FEV1%, FVC%, FEV1/FVC and PEFR% with a signiﬁcant reduction of BMI and serum leptin
levels.
Conclusion: Reduction mammoplasty can play a role in improving restrictive pulmonary func-
tion parameters while diet control regimen has a more signiﬁcant improvement in both obstructive
and restrictive pulmonary function parameters and in the reduction of BMI and serum leptin level
in obese subjects with macromazia.
ª 2013 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis.Open access under CC BY-NC-ND license.Introduction
Before the 20th century, obesity was rare. In 1997 the WHO
formally recognized obesity as a global epidemic. As of 2005
the WHO estimates that at least 400 million adults (9.8%)
are obese, with higher rates among women than men. The rate
of obesity also increases with age at least up to 50 or 60 years
and severe obesity in the United States was recorded [1].
Obesity may lead to various complications, including pul-
monary function abnormalities. The most common abnormal-
ities in obese adults are decreased expiratory ﬂow rates and
lung volumes [2].
Also, obesity may be associated with breast hypertrophy or
gigantomastia [3]. Subjects with breast hypertrophy with obes-
ity are suffering not only from cosmetic aspects but negatively
affected their quality of life [4].
So, bilateral breast reduction is the surgical treatment for
bilateral breast hypertrophy. Most of the outcome measures
for assessing the results of the procedure are subjective; thus,
there is a need to produce objective and measurable beneﬁts of
bilateral breast reduction. One suchmeasure is the lung function
test. Macromastia leads to a relative restriction in chest wall
compliance; therefore, reduction of breast size should enhance
chest wall compliance and lead to improved ventilation [5].
Serum leptin level is increased in obesity in proportion to the
amount of body fat, gender and fat distribution into subcutane-
ous or visceral adipose tissue depots that contribute to greater
serum leptin in women than men of equivalent fat mass [6].
The ability of leptin to augment airway hyperresponsive-
ness through increased activation of mast cells is possible, di-
rect effect of leptin on the airway smooth muscle, or through
the potentiation action of leptin on other inﬂammatory medi-
ators that cause smooth muscle contraction is seen [7].
Diet programs may produce weight loss in 67% of people
who lost greater than 10% of their body mass and maintained
or continued to lose weight one year later. An average main-
tained weight loss of more than 3 kg or 3% of total body mass
could be sustained for ﬁve years [8].
Leptin production regulation in humans is poorly under-
stood, but appears to depend on the total body fat and changes
in energy intake through diet programs [6].
So, the aim of this study was to evaluate the effect of weight
reduction versus reduction-mammoplasty on pulmonary func-
tion parameters and serum-leptin level in obese patients with
macromazia.Subjects and methods
Subjects
This study was carried out in Chest, Internal Medicine, Plastic
Surgery and Clinical Pathology Departments, Faculty of Med-
icine, Zagazig University fromAugust 2010 toMay 2012. Forty
females with obesity and macromazia were included in the
study. Their age range was 16–42 years and body mass index
was 30–35 kg/m2. They were suffering from physical symptoms
such as breathlessness, cosmetic and psychosocial problems.
The studied subjects were classiﬁed into two groups, group (1)
(the surgical group) included twenty females who were seeking
surgery (reduction mammoplasty) to get relief from their symp-
toms, group (2) (diet regimen group) included twenty females
who refused surgery and were seeking diet-control regimen.
Informed consents were obtained from our patients before
surgery and after explanation of the whole procedure to them.
Methods
All subjects were subjected to:
(1) Thorough medical history and clinical examination.
(2) Dyspnea score using modiﬁed Borg category scale [9].
(3) Body mass index (BMI) calculation according to WHO
[10] as follows:
BMI
Weight in ðkgÞ
Square of his height in square meters ðm2Þ
(1) Plain chest X-ray PA and lateral views.
(2) Routine laboratory investigation before operation (e.g.,
CBC, INR, renal and hepatic proﬁle).
(3) Pre and post-procedure serum leptin level (after
3 months of the procedure).
a. Sample collection: whole blood should be collected
into centrifuge tubes containing anticoagulant and
centrifuged immediately after collection. Specimens
should be frozen only once at 20 C prior to assay.
b. Leptin measurement done by using the DRG leptin
ELISA kit (DRG international, Inc., USA) which is
a solid phase enzyme linked immunosorbent assay
(ELISA) based on the Sandwich Principle.
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ml.
(4) Pre and post-procedure by 3 months, pulmonary func-
tion tests were carried out using ZAN-100 (Flow Handy
II) pulmonary function apparatus and guided by the
American Thoracic society (ATS) standards.
The subjects were asked to do multiple trials (3 trials) with
maximum efforts and we considered the results obtained after
three plateaus as preoperative values to exclude the positive
learning effect on pulmonary function results [11]. All individ-
uals were tested for FVC% (Forced vital capacity percent of
predicted), FEV1% (Forced expiratory volume in one second
percent of predicted), PEFR% (peak expiratory ﬂow rate per-
cent of predicted) and FEV1/FVC (the ratio of forced expira-
tory volume in one second to forced vital capacity).
Pulmonary function parameters were assessed again three
months post-diet control program and post-surgery to give a
chance for the healing of the wound and to deprive the effect
of pain on the pulmonary function results. All tests were car-
ried by the same team.Interpretation of pulmonary function parameters
Every parameter obtained by spirometric pulmonary function
testing was expressed as a percentage (%) from predicted val-
ues, and depending on the results patients were categorized as
follows: normal pulmonary functions 80–100% of predicted,
obstructive if FEV1/FVC < 70%, restrictive if FVC < 80%
of predicted and FEV1/FVC > 70%, combined obstructive
and restrictive if FVC < 80% of predicted and FEV1/
FVC< 70% [12].
(1) Diet-control regimen according to general diet guide-
lines for achieving and maintaining a healthy weight
[13].
Calorie counting is the best way to lose weight. According
to the British Nutrition Foundation [14], to lose weight, the en-
ergy intake from food must be less than the energy output.
Thus calorie counting is the most effective weight loss method.
Weight-loss phase for twelve weeks, participants were in-
structed to be on caloric restriction by calculating their calories
in all three of their daily meals.
Calculation of total energy expenditure was done by using
this formula:
Total daily energy expenditureðTDEEÞ
¼ BMRX ½time in bedþ ðtime at work XPARÞ
þ ðNon-occupational time PARÞ:
BMR: basal metabolic rate. PAR: the physical activity ratio.
We also use the web site (Calories count-com) to enter the
patients data and then calculate the modiﬁed calories plan
needed.
(1) All subjects who underwent surgery had bilateral reduc-
tion mammoplasty in the same sitting. Inferiorly based
pedicle was our selected technique, as it has the lowest
rate of complication in the large sized breast [15].Statistical analysis
Data were checked, entered and analyzed by using SPSS ver-
sion 19. Data were expressed as mean ± SD for quantitative
variables. Paired t-test and correlation were used when appro-
priate P< 0.05 was considered statistically signiﬁcant.Results
On analysis of the results, Table 1 shows that the studied
groups are matched as regards age, BMI and dyspnea scores.
Table 2 shows that, there is a non-signiﬁcant difference be-
tween pre and post surgery patients regarding FEV1%, FEV1/
FVC and PEFR% but, there is a highly signiﬁcant difference
as regards FVC%. On the other hand, there is a signiﬁcant dif-
ference between pre and post diet control regimen regarding
FEV1%, FVC%, FEV1/FVC and PEFR%.
Table 3 illustrates that obese subjects with higher BMI have
combined pulmonary dysfunction (restrictive and obstructive)
whereas obese subjects with lower BMI have restrictive pul-
monary dysfunction only and the difference was statistically
highly signiﬁcant.
Table 4 shows that subjects with restrictive and combined
pulmonary dysfunction have lower serum leptin level after sur-
gery but the difference between pre and post-surgery serum
leptin levels was non-signiﬁcant.
Table 5 shows that subjects with restrictive pulmonary dys-
function have lower serum leptin level after diet control but the
difference between pre and post diet control was non-signiﬁ-
cant. On the other hand, subjects who have combined pulmon-
ary dysfunction demonstrated lower serum leptin level post-
diet control and the difference between pre and post-diet con-
trol was statistically highly signiﬁcant.
Table 6 shows that there is non-signiﬁcant decrease of body
mass index and serum leptin level 3 months after surgery.
Table 7 shows that there is a highly signiﬁcant decrease of
body mass index and serum leptin-level 3 months after diet
control-regimen.
Table 8 shows that there is marked decrease of BMI and
serum leptin in the diet control group than the surgical group
and the difference between both groups is statistically highly
signiﬁcant.
Fig. 1 shows that there is highly signiﬁcant correlation be-
tween BMI and serum leptin levels before and 3 months after
surgery.
Fig. 2 shows that there is highly signiﬁcant correlation be-
tween BMI and serum leptin levels before and 3 months after
diet control.
Fig. 3 shows that there is highly signiﬁcant correlation be-
tween changes of BMI and serum leptin level in both surgical
and diet control groups.Discussion
Obesity may lead to various complications, including pulmon-
ary function abnormalities. The most common abnormalities
in obese adults are decreased expiratory ﬂow rates and lung
volumes [2].
Leptin is one of the adipose tissue products that participate
in body weight control. Leptin circulates at concentrations
Table 1 Demographic data of studied groups before the intervention.
Demographic data
(mean ± SD)
Surgical group Diet control group P-value
Age 29.4 ± 6.7 31.75 ± 6.87 0.28 NS
BMI (kg/m2) 33.6 ± 1.0 32.9 ± 1.3 0.09 NS
Dyspnea score 2.1 ± 1.05 1.97 ± 0.8 0.8 NS
Table 2 Distribution of PFTs among the studied groups before and after intervention.
PFTs Surgical group P-value Diet control group P-value
Pre Post Pre Post
FEV1% 77.4 ± 8.8 79.2 ± 6.2 0.02 NS 76.9 ± 1.1 82.7 ± 4.3 <0.001
*
FVC% 75.2 ± 5.5 84.3 ± 3.7 <0.001* 78.1 ± 2.3 84.2 ± 2.1 <0.001*
FEV1/FVC 85.9 ± 3.3 82.9 ± 3.1 >0.05 NS 80.48 ± 3.4 88.21 ± 2.3 <0.001
*
PEFR% 97.2 ± 4.1 81.8 ± 2.2 0.16 NS 78.2 ± 6.2 83.5 ± 9.4 <0.001*
Table 3 Relationship between BMI (mean ± SD) and PFTs among all patients of the studied groups.
Pulmonary function tests BMI (kg/m2) t P-value
Mean ± SD Range
Restrictive 32.7 ± 1.1 30.4–33.8 2.15 0.037*
Sig.Combined obst. + restrict. PFTs 33.6 ± 1.0 31.5–35.0
Table 4 Serum leptin level versus PFTs in the surgical group before and 3 months after surgery.
Leptin level (ng/ml) PFTs
Restrictive pulmonary
dysfunction
Combined obstructive and
restrictive pulmonary dysfunction
Pre-surgery mean ± SD
(range)
7.4 ± 3.4 10.5 ± 2.96
(3.66–14.48) (3.32–14.28)
Post surgery mean ± SD
(range)
6.7 ± 3.3 9.8 ± 2.8
(3.32–12.38) (3.10–13.28)
P-value 0.07 0.08
Table 5 Serum leptin level and PFTs in the diet-control group before and 3 months after the diet control regimen.
Leptin level (ng/ml) PFTs
Restrictive pulmonary
dysfunction
Combined obstructive and restrictive
pulmonary dysfunction
Pre-diet control mean ± SD
(range)
8.36 ± 3.5 10.2 ± 3.1
(4.34–14.76) (4.83–14.90)
Post diet control mean ± SD
(range)
8.1 ± 2.8 7.47 ± 2.4
(3.9–11.6) (3.32–10.86)
P-value 0.06 <0.001*
Table 6 Mean values ± SD of BMI and serum leptin level
before and 3 months after surgery.
Before surgery After surgery P-value
BMI 33.0 ± 1.34 32.7 ± 1.2 0.11 NS
Serum leptin 9.28 ± 3.28 8.9 ± 3.27 0.07 NS
Table 7 Mean values ± SD of BMI and serum leptin level pre
and 3 months after diet control regimen.
Pre diet 3 months after diet P-value
BMI 33.9 ± 1.04 29.6 ± 0.9 <0.001*
Serum leptin 9.45 ± 3.3 6.67 ± 2.4 <0.001*
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Table 8 Percentage of reduction in BMI and serum leptin
among study groups 3 months after the intervention.
Diet control group
(N= 20)
Surgery group
(N= 20)
P
BMI 12.8 0.9 <0.001**
Leptin 29.8 4.1 <0.001**
r =0.91, P<0.001
-40.0
-35.0
-30.0
-25.0
-20.0
-15.0
-10.0
-5.0
0.0
-20.00 -15.00 -10.00 -5.00 0.00 5.00
BMI change
Le
pt
in
 c
ha
ng
e
surgical 
diet control 
Figure 3 Correlation between changes of BMI and serum leptin
levels in both surgical and diet control groups.
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circulating leptin falls during starvation. Leptin always de-
creases after weight loss [16].
Also, obesity may be associated with breast hypertrophy or
gigantomastia [3]. Subjects with breast hypertrophy with obes-
ity are suffering not only from cosmetic aspects but negatively
affected the quality of life [4].
Theoretically, heavy bulky breast can restrict chest wall
movement and reduction of this weight may lead to the
improvement of lung ventilation [5].
Mammoplasty is one of procedures that removes a large
amount of subcutaneous fat and is considered as a type of
bariatric surgery [17].
So, the aim of this study was to evaluate the effect of weight
reduction versus reduction-mammoplasty on parameters of
pulmonary function and serum-leptin level in obese patients
with macromazia.
Table 1 showed that the patients in the diet control group
and those in the surgery group were matched as regards age
and body mass index (BMI) but there are statistically non-sig-
niﬁcant higher dyspnea scores. Patients who had reductionr = 0.98, P<0.001
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r = 0.79, P<0.001
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Figure 2 Correlation between BMI and serum leptin levmammoplasty were more dyspneic than those in the diet con-
trol group. This can explain why those patients sought surgery
because of the more distressing dyspnea from which they suf-
fer. Also, this can be explained by, heavy bulky breasts that
may restrict chest wall movement.
Table 2 illustrated that patients who underwent reduction
mammoplasty have non-signiﬁcant difference between pre
and post surgery values of FEV1%, FEV1/FVC and PEFR%
but have a signiﬁcant improvement regarding FVC%. This
indicates the improvement of restrictive pulmonary dysfunc-
tion in those patients after surgery.
These results were matched with Starley et al. [18] who doc-
umented an improvement of pulmonary function tests
(FVC%, PEFR%, PIFR%) after reduction mammoplasty by
6–8 weeks.r = 0.89, P<0.001
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728 R. Nafae et al.Also, Sood et al. [19] showed that reduction mammoplasty
accompanied with a signiﬁcant improvement in pulmonary
function including inspiratory capacity, peak expiratory ﬂow
rate and maximal voluntary ventilation (P< 0.05).
These results can be explained by the fact that obesity in
association with macromastia may lead to a relative restriction
in chest wall compliance therefore, reduction of breast size is
expected to enhance chest wall compliance and improve
ventilation.
On the other hand, patients in the diet control group
showed signiﬁcant difference in FEV1% and FVC% and
PEFR% indicating improvement in those parameters.
This result is concomittent with Aaron et al. [20] who re-
ported increases in FEV1 and FVC in obese women after
diet-induced weight reduction.
Table 3 denotes that patients with higher body mass index
(BMI) had combined obstructive and restrictive pulmonary
dysfunction whereas those with lower BMI had restrictive pul-
monary dysfunction only.
Spathapoulos et al. [21] reported that PFT parameters
(FEV1, FVC, FEF25–75 and FEV1/FVC) were decreased in
over weight and obese cases (high BMI).
Also, the most common abnormality found was combined
restrictive and obstructive type. This may be explained by
extrinsic mechanical compression due to fat accumulation
which causes decreased chest wall recoil and compliance result-
ing in expiratory volume reduction. Nevertheless, a mechanical
effect was not the only factor since, pulmonary function
parameters were affected by increased serum leptin levels in
obese subjects [22].
Tables 4 and 5 showed that post-diet regimen, S-leptin level
had a highly signiﬁcant decrease in subjects with combined
obstructive and restrictive pulmonary dysfunction. In the sur-
gery group there was non signiﬁcant decrease of serum leptin
after surgery in patients having restrictive and combined pul-
monary dysfunction.
This indicates the sharing effect of raised serum leptin in
inducing obstructive pulmonary dysfunction in addition to
the restrictive abnormality noticed in obese patients.
Tables 6 and 7 showed that there is a statistically highly sig-
niﬁcant difference between pre and post-diet control regimen
subjects regarding BMI and serum leptin level, while there is
non-signiﬁcant difference between pre and post-reduction
mammoplasty regarding BMI and serum leptin levels.
These results can be explained by, the fact that diet control
regimen decreases markedly the amount of body fat as a whole
leading to decrease in leptin production and BMI while reduc-
tion mammoplasty results in considerable weight loss that low-
ers BMI mainly and possible improvement in lung function
secondary to decreasing BMI that is caused by the resected
specimen [23].
Table 8 shows that there is marked decrease of BMI and
serum leptin in the diet control group than the surgical group
and the difference between both groups is statistically highly
signiﬁcant.
This result is concomitant with Rinomhota et al. [24], who
reported alack of statistically signiﬁcant difference in body
weight changes (BMI) in the bilateral breast reduction group
while higher signiﬁcant difference was seen in the abdomino-
plasty group. Also, Owecki et al. [25] reported that dietary in-
duced weight loss is followed by a decrease in leptin level.Serum leptin concentrations are correlated with the per-
centage of body fat, suggesting that most obese persons are
insensitive to endogenous leptin production [26].
Conclusion
Reduction mammoplasty can play a role in improving restric-
tive pulmonary dysfunction while diet control regimen has a
more signiﬁcant improvement in both obstructive and restric-
tive pulmonary function parameters and also, in decreasing
serum leptin level in obese subjects with macromazia.
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